Stock Track | LifeStance Health Soars 10% Pre-Market on Strong Q2 Results and Positive Q3 Outlook

Stock Track
08/07

LifeStance Health Group, Inc. (LFST) shares surged 10.00% in pre-market trading on Thursday following the release of its second-quarter 2025 financial results and third-quarter outlook. The company's performance exceeded analyst expectations in several key areas, demonstrating resilience and growth potential in the healthcare sector.

LifeStance reported a narrower-than-expected net loss of $3.8 million for Q2, significantly beating the IBES estimate of a $9.87 million loss. The company's adjusted EBITDA came in at $34 million, surpassing the expected $31.1 million. Revenue for the quarter reached $345.3 million, slightly above the anticipated $345.2 million, indicating steady growth and market demand for LifeStance's services.

Looking ahead, LifeStance provided an optimistic outlook for the third quarter of 2025. The company forecasts Q3 revenue between $345 million and $365 million, with adjusted EBITDA projected to range from $33 million to $39 million. This positive guidance suggests continued momentum and operational efficiency, likely contributing to investor enthusiasm and the subsequent pre-market stock rally.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10